Researchers at Mass General Brigham found that a nasal spray delivering anti-CD3 (Foralumab) reduces neuroinflammation, limits central nervous system damage and improves behavioral outcomes in mice with traumatic brain injury.
#Medsky https://www.technologynetworks.com/drug-discovery/news/nasal-spray-shows-promise-in-treating-traumatic-brain-injury-396639

Comments